31 March 2025
: Case report
Overcoming Cytomegalovirus Induced Immune Thrombocytopenia in Immunocompetent Adults – A Case of Antiviral Therapy Efficacy
Challenging differential diagnosis, Diagnostic / therapeutic accidents, Unusual setting of medical care, Unexpected drug reaction, Rare disease
Sujatha Baddam ABCDEFG 1*, Mrudula Thiriveedi E 2, Siddharth PatelDOI: 10.12659/AJCR.947070
Am J Case Rep 2025; 26:e947070
Table 2. Microbiology serology.
| Description | Result | Reference range | Units |
|---|---|---|---|
| CMV IgG | Negative | Negative | |
| CMV IgM | Positive | Negative | |
| CMV DNA Qn by PCR | 8790 | Undetected | IU/mL |
| EBV VCA IgM Ab | Negative | Negative | |
| EBV VCA IgG Ab | Negative | Negative | |
| Parvovirus B19 Ab, IgG | Negative | Negative | |
| Parvovirus B19 Ab, IgM | Negative | Negative | |
| Ehrlichia Chaffeensis (HME) Ab, IgG | <1: 64 | <1: 64 | |
| Anaplasma phagocytophilum Ab, IgG, S | <1: 64 | <1: 64 | |
| Babesia microti IgG Ab, S | <1: 64 | <1: 64 | |
| Lyme disease serology, S | Negative | Negative | |
| HIV 1 and 2 antigen and antibody screen | Non-reactive | Non-reactive | |
| Hepatitis screen | Non-reactive | Non-reactive |






